Brompton Funds: Cash Flow Kings ETF

Brompton's Cash Flow Kings ETFs target high cash flow yielding companies, ensuring strong returns and financial stability for investors.

Brompton Funds: Cash Flow Kings ETF

Brompton's Cash Flow Kings ETFs invest in mid- to large-cap companies with high free cash flow yields, focusing on companies that are attractively valued relative to their cash generating abilities. Companies with high levels of free cash flow (excess cash) are not only financially stable but they also have opportunities to increase shareholder value. Free cash flow is the fuel that powers a company’s growth and profitability.

Brompton Cash Flow Kings ETFs (KNGC, KNGU, KNGX) are designed to replicate the Brompton Index One Cash Flow Kings Indices. These indices track the performance of Canadian, US, and International companies with robust free cash flow relative to their enterprise value. With low management fees of 0.45% (KNGC/KNGU) and 0.55% (KNGX), these ETFs offer a cost-effective way to gain exposure to companies with high free cash flow, trading at attractive valuations.

For more information on Brompton Cash Flow Kings ETFs please contact Brompton Funds.

You might also like

Kirkland Lake Discoveries Targets Multi-Mineral Potential in Ontario
Metals & Mining
March 13, 2026

Kirkland Lake Discoveries Targets Multi-Mineral Potential in Ontario

Exploration in mature camps often centers on new interpretations of old systems. Kirkland Lake Discoveries is testing that thesis.

This is some text inside of a div block.
CEO Clips - Kirkland Lake Discoveries Advances 25,000m Drill Program in Historic Ontario Camp
Metals & Mining
March 13, 2026

CEO Clips - Kirkland Lake Discoveries Advances 25,000m Drill Program in Historic Ontario Camp

Kirkland Lake has been a producing mining camp for more than 100 years.

This is some text inside of a div block.
Picard Medical Advancing Total Artificial Heart Technology
Health & Wellness
March 11, 2026

Picard Medical Advancing Total Artificial Heart Technology

The potential need for technologies like total artificial hearts remains significant as the number of patients with advanced heart failure continues to outpace the availability of donor organs.

This is some text inside of a div block.
Subscribe and receive the investor Info